Prosecution Insights
Last updated: August 15, 2026

Grail LLC

29 pending office actions • 8 art units • 23 examiners • 0 of 29 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days

Portfolio Summary

29
Total Pending OAs
13
Non-Final OAs
14
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
0
Due this week
7
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)Due ≤ 30 days (7)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

24
Hard (83%)
3
Medium (10%)
2
Easy (7%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only2 (7%)
§101 + other18 (62%)
§103 only2 (7%)
§102 only1 (3%)
§112 only1 (3%)
Double-patenting only1 (3%)
Multi-statute (no §101)4 (14%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

26
Life Sciences
90% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
3% of docket
2
Business / Other
7% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

290 h
Manual time on pending OAs
58 h
Time saved (low, 20%)
102 h
Time saved (mid, 35%)
2.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DHARITHREESAN, NIDHI 2 40.0% +35.1%
HAYES, JONATHAN EDWARD 2 37.5% +23.5%
MINCHELLA, KAITLYN L 2 26.9% +22.1%
VASSELL, MEREDITH ABBOTT 2 29.7% +47.1%
WILDER, CYNTHIA B 2 71.0% +26.7%
PLAYER, ROBERT AUSTIN 2 14.3% +44.1%
LIU, GUOZHEN 1 48.5% +26.5%
SALMON, KATHERINE D 1 42.6% +38.0%
SCHLOOP, ALLISON ELIZABETH 1 58.5% +60.8%
KALLAL, ROBERT JAMES 1 60.6% +33.7%

Hard Cases (24)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17144021 BITERMINAL DNA FRAGMENT TYPES IN CELL-FREE SAMPLES AND USES THEREOF HAYES, JONATHAN EDWARD 112d overdue
17105175 SYSTEMS AND METHODS FOR EVALUATING LONGITUDINAL BIOLOGICAL FEATURE DATA AUGER, NOAH ANDREW 104d overdue
17050372 SYSTEMS AND METHODS FOR USING PATHOGEN NUCLEIC ACID LOAD TO DETERMINE WHETHER A SUBJECT HAS A CANCER CONDITION PLAYER, ROBERT AUSTIN 97d overdue
16721619 CELL-FREE DNA END CHARACTERISTICS MINCHELLA, KAITLYN L 93d overdue
18267769 PREPARATION OF NUCLEIC ACID SAMPLES FOR SEQUENCING WILDER, CYNTHIA B 49d overdue
16235901 MICROSATELLITE INSTABILITY DETECTION SCHULTZHAUS, JANNA NICOLE 5d overdue
17714062 CONDITIONAL TISSUE OF ORIGIN RETURN FOR LOCALIZATION ACCURACY LUO, JAMMY NMN 13d
17931016 METHODS FOR ANALYSIS OF TARGET MOLECULES IN BIOLOGICAL FLUIDS HAQ, SHAFIQUL 20d

Interview Candidates (16)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18183002 METHODS OF ANALYZING NUCLEIC ACID FRAGMENTS WILDER, CYNTHIA B 175d overdue
17144021 BITERMINAL DNA FRAGMENT TYPES IN CELL-FREE SAMPLES AND USES THEREOF HAYES, JONATHAN EDWARD 112d overdue
17050372 SYSTEMS AND METHODS FOR USING PATHOGEN NUCLEIC ACID LOAD TO DETERMINE WHETHER A SUBJECT HAS A CANCER CONDITION PLAYER, ROBERT AUSTIN 97d overdue
16721619 CELL-FREE DNA END CHARACTERISTICS MINCHELLA, KAITLYN L 93d overdue
18267769 PREPARATION OF NUCLEIC ACID SAMPLES FOR SEQUENCING WILDER, CYNTHIA B 49d overdue
18011145 METHYLATED DNA FRAGMENT ENRICHMENT, METHODS, COMPOSITIONS AND KITS SALMON, KATHERINE D 23d
17817421 SOMATIC VARIANT COOCCURRENCE WITH ABNORMALLY METHYLATED FRAGMENTS KALLAL, ROBERT JAMES 28d
17957643 SEQUENCING OF VIRAL DNA FOR PREDICTING DISEASE RELAPSE SCHLOOP, ALLISON ELIZABETH 30d

Top Art Units

Art UnitApps
1686 8
1685 7
1681 5
1682 2
1687 2
1683 1
1678 1
3619 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18661452 SIZE-TAGGED PREFERRED ENDS AND ORIENTATION-AWARE ANALYSIS FOR MEASURING PROPERTIES OF CELL-FREE MIXTURES LIU, GUOZHEN 1686 §101§103§112 Non-Final OA Pending May 10, 2024
18011145 METHYLATED DNA FRAGMENT ENRICHMENT, METHODS, COMPOSITIONS AND KITS SALMON, KATHERINE D 1682 §103§112 Final Rejection 23d Pending Dec 16, 2022
17957643 SEQUENCING OF VIRAL DNA FOR PREDICTING DISEASE RELAPSE SCHLOOP, ALLISON ELIZABETH 1683 §101§103Other Final Rejection 30d Pending Sep 30, 2022
17817421 SOMATIC VARIANT COOCCURRENCE WITH ABNORMALLY METHYLATED FRAGMENTS KALLAL, ROBERT JAMES 1685 §101§102§103§112 Non-Final OA 28d Pending Aug 04, 2022
17860577 ANALYSIS OF MICROBIAL FRAGMENTS IN PLASMA PRIEST, AARON A 1681 §102§103 Non-Final OA Pending Jul 08, 2022
17478856 DETECTING CROSS-CONTAMINATION IN SEQUENCING DATA DHARITHREESAN, NIDHI 1686 §101§102§112 Non-Final OA Pending Sep 17, 2021
17374691 NUCLEASE-ASSOCIATED END SIGNATURE ANALYSIS FOR CELL-FREE NUCLEIC ACIDS GIAMMONA, FRANCESCA FILIPPA 1681 §101§103 Final Rejection Pending Jul 13, 2021
17144021 BITERMINAL DNA FRAGMENT TYPES IN CELL-FREE SAMPLES AND USES THEREOF HAYES, JONATHAN EDWARD 1685 §101 Final Rejection 112d overdue Pending Jan 07, 2021
17105175 SYSTEMS AND METHODS FOR EVALUATING LONGITUDINAL BIOLOGICAL FEATURE DATA AUGER, NOAH ANDREW 1687 §101§112 Non-Final OA 104d overdue Pending Nov 25, 2020
16936901 SYSTEMS AND METHODS FOR DETERMINING TUMOR FRACTION HAYES, JONATHAN EDWARD 1685 §103 Final Rejection Pending Jul 23, 2020
16723369 SYSTEMS AND METHODS FOR USING FRAGMENT LENGTHS AS A PREDICTOR OF CANCER SABOUR, GHAZAL 1686 §101§103 Final Rejection Pending Dec 20, 2019
16721619 CELL-FREE DNA END CHARACTERISTICS MINCHELLA, KAITLYN L 1685 §101§112DP Final Rejection 93d overdue Pending Dec 19, 2019
16719902 SYSTEMS AND METHODS FOR ESTIMATING CELL SOURCE FRACTIONS USING METHYLATION INFORMATION KRIANGCHAIVECH, KETTIP 1686 §101§103 Final Rejection Pending Dec 18, 2019
16579805 MIXTURE MODEL FOR TARGETED SEQUENCING VASSELL, MEREDITH ABBOTT 1687 §101 Final Rejection Pending Sep 23, 2019
16235901 MICROSATELLITE INSTABILITY DETECTION SCHULTZHAUS, JANNA NICOLE 1685 §101§112 Non-Final OA 5d overdue Pending Dec 28, 2018
18605798 Models for Targeted Sequencing FRUMKIN, JESSE P 1685 §101§103Other Non-Final OA 22d Pending Mar 14, 2024
18267769 PREPARATION OF NUCLEIC ACID SAMPLES FOR SEQUENCING WILDER, CYNTHIA B 1681 §102§103 Non-Final OA 49d overdue Pending Jun 15, 2023
18298043 ENRICHMENT OF MUTATED CELL FREE NUCLEIC ACIDS FOR CANCER DETECTION ZHANG, KAIJIANG §102 Non-Final OA Pending Apr 10, 2023
18183002 METHODS OF ANALYZING NUCLEIC ACID FRAGMENTS WILDER, CYNTHIA B 1681 DP Final Rejection 175d overdue Pending Mar 13, 2023
18169834 TUMOR FRACTION ESTIMATION USING METHYLATION VARIANTS VASSELL, MEREDITH ABBOTT §101§102§103§112 Non-Final OA Pending Feb 15, 2023
18147647 COMPOSITIONS AND METHODS FOR IDENTIFYING CELL TYPES KIM, YOUNG J 1681 §103§112 Final Rejection Pending Dec 28, 2022
17931016 METHODS FOR ANALYSIS OF TARGET MOLECULES IN BIOLOGICAL FLUIDS HAQ, SHAFIQUL 1678 §101§103§112 Non-Final OA 20d Pending Sep 09, 2022
17714062 CONDITIONAL TISSUE OF ORIGIN RETURN FOR LOCALIZATION ACCURACY LUO, JAMMY NMN 1686 §101§103 Non-Final OA 13d Pending Apr 05, 2022
17641712 Read-Tier Specific Noise Models for Analyzing DNA Data WHALEY, PABLO S 3619 §112 Non-Final OA Pending Mar 09, 2022
17638904 SYSTEMS AND METHODS FOR PREDICTING AND MONITORING TREATMENT RESPONSE FROM CELL-FREE NUCLEIC ACIDS PLAYER, ROBERT AUSTIN 1686 §101§103 Final Rejection Pending Feb 28, 2022
17384241 DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE BUCHANAN, BAILEY CHEYENNE 1682 §101§103§112Other Final Rejection 23d Pending Jul 23, 2021
17185885 SYSTEMS AND METHODS FOR CALLING VARIANTS USING METHYLATION SEQUENCING DATA DHARITHREESAN, NIDHI 1686 §103 Non-Final OA Pending Feb 25, 2021
17050372 SYSTEMS AND METHODS FOR USING PATHOGEN NUCLEIC ACID LOAD TO DETERMINE WHETHER A SUBJECT HAS A CANCER CONDITION PLAYER, ROBERT AUSTIN 1686 §101§103§112DP Final Rejection 97d overdue Pending Oct 23, 2020
17006124 SYSTEMS AND METHODS FOR DETERMINING CONSENSUS BASE CALLS IN NUCLEIC ACID SEQUENCING MINCHELLA, KAITLYN L 1685 §101§103§112 Non-Final OA Pending Aug 28, 2020

Managing Grail LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month